Abdulbaki Aǵbaş

This study profiles platelet bioenergetics in diabetes patients, finding reduced non-mitochondrial oxygen consumption as a potential biomarker for diabetic complications.

This study identifies post-translational modifications of TDP-43 in platelets from Alzheimer's patients compared to controls, suggesting potential blood-based biomarkers for early diagnosis.

This study identifies exosomal TDP-43 as a potential biomarker in canine degenerative myelopathy, suggesting serum-derived exosomes could serve as a non-invasive tool for neurodegenerative disease biomarker development.

The paper assesses platelet proteolytic machinery in Alzheimer's Disease, finding elevated LC3-I levels in AD patients but no significant proteasome differences.

The paper investigates impaired Cn-SOD1 interaction in ALS models, linking it to TDP-43 hyperphosphorylation and zinc aggregation.

This study explores platelet phosphorylated TDP-43 as a potential peripheral biomarker for early Alzheimer’s disease detection and monitoring.